Centrally acting sympatholytics are centrally acting antihypertensives that reduce sympathetic outflow from the brain. They are sometimes grouped with adrenergic agents because their effect is mediated through adrenergic signaling, but the key bedside point is location: these medications work in the central nervous system rather than directly on peripheral blood vessels. By decreasing sympathetic tone, they reduce norepinephrine release, lower heart rate, reduce peripheral vascular resistance, and lower blood pressure. Clonidine and methyldopa are the high-yield nursing exemplars. They are not usually first-line for uncomplicated hypertension, but they remain important in selected hypertension, resistant hypertension, pregnancy-associated hypertension for methyldopa, ADHD-related clonidine use, and withdrawal-symptom protocols. Teaching Pearl: These medications work in the brain rather than directly on peripheral blood vessels. On the exam, writers often pair stable-sounding options with unstable data—notice the mismatch before you commit. If the stem names a license or role, reread that line; scope errors are classic trap answers even when the clinical topic is familiar. Run a 60-second scan: breathing work and oxygenation, perfusion and end organs, neuro baseline, likely infection sources, and devices that...